Home LiteratureArticle Details
PMID: 15194680 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Histone deacetylase activity is required to recruit RNA polymerase II to the promoters of selected interferon-stimulated early response genes.

The Journal of biological chemistry ·Vol. 279 ·No. 39 ·2004-09-24 ·Pages 40362-7

Sakamoto S, Potla R, Larner AC

Abstract

Posttranslational modification of histones by acetylation, methylation or phosphorylation has emerged as a major mechanism to modify chromatin structure and gene expression. In most cases, transcriptionally active genes display enhanced binding of acetylated histones in their promoters. Activation of histone acetyltransferases or inhibition of histone deacetylases (HDACs) allows chromatin to assume a more open state permitting transcriptional activators to form a preinitiation complex. To our surprise, treatment of cells with the HDAC inhibitor, trichostatin A (TSA), inhibits selected interferon beta (IFNbeta)-stimulated immediate early genes that are activated by the transcription factors Stat1 and Stat2. However, IFNbeta activation of IRF-1, which requires tyrosine-phosphorylated Stat1 homodimers binding to a gamma interferon activation sequence in its promoter is not affected by TSA. Exposure of cells to TSA does not alter tyrosine phosphorylation of Stat1 or Stat2. TSA treatment of cells also does not alter the binding of Stat 1 or Stat2 to the endogenous ISG54 promoter. However, IFNbeta-stimulated binding of RNA polymerase II to the ISG54 promoter is prevented by TSA. Interestingly, ectopic expression of IRF9 reverses the inhibitory actions of TSA, suggesting that IRF9 functions to recruit RNA polymerase II to the promoter of interferon-stimulated genes. This particular function of IRF9 requires the activity of histone deacetylases.

MeSH Terms
Cell Line Chromatin/metabolism DNA-Binding Proteins/metabolism,physiology Dimerization Fibroblasts/metabolism Gene Expression Regulation Histone Deacetylases/metabolism Humans Hydroxamic Acids/pharmacology Interferon Regulatory Factor-1 Interferon-Stimulated Gene Factor 3 Interferon-Stimulated Gene Factor 3, gamma Subunit Interferon-beta/metabolism Interferons/metabolism Luciferases/metabolism Phosphoproteins/metabolism Phosphorylation Precipitin Tests Promoter Regions, Genetic Protein Binding RNA Polymerase II/metabolism,physiology STAT1 Transcription Factor STAT2 Transcription Factor Time Factors Trans-Activators/metabolism Transcription Factors/metabolism,physiology Transcription, Genetic Tyrosine/metabolism
Chemicals
Chromatin DNA-Binding Proteins Hydroxamic Acids IRF1 protein, human IRF9 protein, human Interferon Regulatory Factor-1 Interferon-Stimulated Gene Factor 3 Interferon-Stimulated Gene Factor 3, gamma Subunit Phosphoproteins STAT1 Transcription Factor STAT1 protein, human STAT2 Transcription Factor STAT2 protein, human Trans-Activators Transcription Factors trichostatin A Tyrosine Interferon-beta Interferons Luciferases RNA Polymerase II Histone Deacetylases
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Sakamoto Shuji
Department of Immunology, Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
Potla Ramesh
Larner Andrew C
Article Info
Journal
The Journal of biological chemistry
Abbr.
J Biol Chem
ISSN
0021-9258
Published
2004-09-24
Epub
2004-00-11
Pages
40362-7
Language
English
Region
United States
NLM ID
2985121R
Subset
IM
Grants
NCI NIH HHS · CA77366 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com